Stockreport

Analysts Expect Breakeven For Cardiol Therapeutics Inc. (TSE:CRDL) Before Long [Yahoo! Finance]

Cardiol Therapeutics Inc. - Class A Common Shares  (CRDL) 
PDF Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart [Read more]